| Cichocka, Danuta (Resistell 201912 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Resistell AG |
Switzerland |
| Cichutek, Klaus (Germany (govt) 202306 President of Paul Ehrlich Institute) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Ciftlik, Ata Tuna (Lunaphore Technologies 201404– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bio-Techne (Group) |
Switzerland |
| Ciller, Carlos (RetinAI Medical 202012 CEO) |
Chief Executive Officer (CEO) |
RetinAI Medical AG |
Switzerland |
| Cimpan, Gabriela (ACD/Labs 201605 Director of Sales Europe) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
United Kingdom (GB) |
| Ciulli, Alessio (Univ Dundee 201607 Associate Professor of Chemical + Structural Biology) |
Professor |
University of Dundee |
United Kingdom (GB) |
| Clackson, Tim (IDRx 202403– CEO before Theseus Pharmaceuticals + Xilio Therapeutics + Ariad Pharmaceuticals + Genentech) |
Chief Executive Officer (CEO) |
IDRx Inc. |
United States (USA) |
| Claessen, Rolf (Freischem Patentanwälte 201005–) |
Patent Attorney |
Freischem & Partner Patentanwälte mbB |
Germany |
| Clark, Chad (Precision for Medicine 201710 COO) |
Chief Operating Officer (COO) |
Precision Medicine Group (Group) |
United States (USA) |
| Clark, Ian T. (Kite Pharma 201701– Non-executive Board Director before Roche/Genentech + Novartis + Sanofi + Ivax) |
Board member, non-executive |
Gilead Sciences (Group) |
United States (USA) |
| Clark, James (Glox Therapeutics 202311 CEO) |
Chief Executive Officer (CEO) |
Glox Therapeutics Ltd. |
United Kingdom (GB) |
| Clark, Martin (MorphoSys 201205– head Central Purchasing + Logistics before Sandoz Biopharmaceuticals + Basilea) |
Commercial Manager_oo |
Novartis (Group) |
Germany |
| Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Clark, Pamela (Pam) (Bruker Corp 201905 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
| Clark, Tim (Univ Erlangen-Nuremberg 200411 Professor) |
Professor |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Germany |
| Clarke, Lindsey (MicrofluidX 202303– VP Commercial before Ori Biotech + Bio-Techne + Miltenyi Biotec) |
Business Development Manager / Strategy Manager |
MicrofluidX Ltd. |
United Kingdom (GB) |
| Clarkson, John (Atlas Genetics 201107 CEO) |
Chief Executive Officer (CEO) |
Atlas Genetics Ltd. |
United Kingdom (GB) |
| Classon, Rolf |
n. a. |
Bayer (Group) |
Germany |
| Classon, Rolf (Bico 202308 Board Chair) |
n. a. |
Bico (Group) |
Sweden |
| Clausnitzer, Nils (VWR International 201705 SVP + President EMA-APAC Lab + Distribution Services) |
President/Director/Head Business Group/Unit/Division |
Avantor (Group) |
United States (USA) |
| Claussen, Carsten (Fraunhofer IME ScreeningPort before European ScreeningPort + Evotec Technologies) |
Managing Director |
Fraunhofer (Group) |
Germany |
| Claussen, Ralf (Eppendorf 201705 Head of Advertising + Communications) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
| Clayman, Michael (Flexion Therapeutics 201712 CEO) |
Chief Executive Officer (CEO) |
Flexion Therapeutics Inc. (Nasdaq: FLXN) |
United States (USA) |
| Cleary, Alan (London Premier College 201203) |
n. a. |
London Premier College |
United Kingdom (GB) |
| Cleiftie, Jean-Sébastien (Erytech 201610– CBO before Sanofi + Innoven Partners + Aventis) |
Chief Business Officer (CBO) |
Erytech (Group) |
France |
| Clein, Mark P. (Precision for Medicine 2012– CEO + Co-Founder before United BioSource Corp) |
Chief Executive Officer (CEO) |
Precision Medicine Group (Group) |
United States (USA) |
| Clémençon, Paul (InSphero 202312– CBO joined 2022 as Head of Business Development) |
Chief Business Officer (CBO) |
InSphero (Group) |
Switzerland |
| Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) |
scientific advisory board (SAB) |
|
|
| Clement, Tom (Qiagen 200901– VP Regulatory and Clinical Affairs before Roche + bioMérieux + Amersham) |
Regulatory Affairs Manager |
Qiagen (Group) |
Netherlands |
| Clement, Wolfgang (BMWA 200501) |
n. a. |
Germany (govt) |
Germany |
| Clevers, Johannes (Hans) (Roche 202202– Head of Roche pRED before Board Durector + Prof at Univ Utrecht) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Clifford, Matt (Entrepreneur First 2020 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Entrepreneur First (EF) |
United Kingdom (GB) |
| Cline, Timothy (Bruker Corp 201804 VP Global Sales at Bruker AXS) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Cloppenburg, Conny (4 Animals AlsterScience GmbH 201409 Managing Director) |
Managing Director |
4 Animals AlsterScience GmbH |
Germany |
| Close, Sven (EnjoyVenture 201208 Senior Investment Manager) |
Investment Manager |
EnjoyVenture (Group) |
Germany |
| Clouston, Myles (MorphoSys 202012 Senior Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
| Clozel, Jean-Paul (Idorsia 20403 CEO + Co-Founder before Actelion) |
Chief Executive Officer (CEO) |
Idorsia (Group) |
Switzerland |
| Clozel, Martine (Actelion 201108 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Cmiljanovic, Vladimir (Piqur Therapeutics 201507 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Piqur Therapeutics AG |
Switzerland |
| Coats, Fiona (Sartorius 202404 Head of Marketing at Lab Products + Services division) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Cobb, Samantha (AdAlta Pty Ltd 201412 CEO) |
Chief Executive Officer (CEO) |
AdAlta Pty Ltd. |
Australia |
| Cocero, Nanette (Pfizer 202004 Global President of Pfizer Vaccines) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Cochlovius, Björn (Eleva 202409 CEO) |
Chief Executive Officer (CEO) |
Eleva GmbH |
Germany |
| Coego Rios, Miguel (Centogene 202206– CFO joined as EVP Finance + Legal in 2/22 before Orphazyme + Mundipharma + Shire) |
Chief Financial Officer (CFO) |
Centogene (Group) |
Germany |
| Coesfeld, Carsten (Bertelsmann 202411 CEO of Bertelsmann Investments) |
Chief Executive Officer (CEO) |
Bertelsmann (Group) |
Germany |
| Cohen, Jon R. (Quest Diagnostics 201103 SVP + CMO) |
Chief Medical Officer (CMO) |
Quest Diagnostics (Group) |
United States (USA) |
| Cohen, Katherine (Panacea Venture 202205 Venture Partner formerly Hookipa Biotech 2011–201606 CEO + Founder + Intercell) |
Managing Director |
Panacea Venture (CN) |
China |
| Cohen-Dayag, Anat (Compugen 201112 CEO) |
Chief Executive Officer (CEO) |
Compugen (Group) |
Israel |
| Cohen-Kutner, Moshik (Omnix Medical 202101 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Omnix Medical Ltd. |
Israel |
| Cohen-Tanugi, Ivan (Eyevensys 201303– CEO before Teva US + Roche Pharma + Amgen) |
Chief Executive Officer (CEO) |
Eyevensys (Group) |
France |
| Colarusso, Thomas (Definiens 201106 VP Sales + Operations at Definiens Inc.) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
United States (USA) |
| Colatrella, Philomena (CSS 202310 CEO) |
Chief Executive Officer (CEO) |
CSS (CH) (Group) (Swiss health insurance) |
Switzerland |
| Cole, Alun (Markes International 200908 Director of ALMSCO International division) |
President/Director/Head Business Group/Unit/Division |
Schauenburg (Group) |
United Kingdom (GB) |
| Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
| Coles, Anthony (Tony) (Cerevel 201909– CEO before Yumanity Therapeutics + Onyx + NPS + Vertex + BMS + Merck US) |
Chief Executive Officer (CEO) |
AbbVie (Group) |
United States (USA) |
| Colinge, Jacques (Austrian Academi of Sciences 201202 Ce-M-M-Research Center for Molecular Medicine) |
Researcher (university / research institute) |
Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften, ÖAW) |
Austria |
| Collan, Robert (FRIBA Investment 202106 Managing Director) |
Managing Director |
FRIBA Investment |
|
| Collasius, Michael (Hombrechtikon Systems Engineering 202406 CEO + Co-Owner before Qiagen 200705 VP Automated Systems) |
Chief Executive Officer (CEO) |
Hombrechtikon Systems Engineering AG (HSE·AG) |
Switzerland |
| Collins, John |
n. a. |
Cosmix (Group) |
Germany |
| Collins, Peter (4titude Ltd 201710 Co-Founder) |
Company Founder |
Azenta (Group) |
United Kingdom (GB) |
| Collins, Peter (Inivata 202009– CBO before Yourgene Health + GSK + Qiagen + DxS) |
Business Development Manager / Strategy Manager |
NeoGenomics (Group) |
United Kingdom (GB) |
| Collins, Ryan (MassMutual 202306 Managing Partner at MassMutual Ventures) |
Managing Partner (investment firm) |
MassMutual (Group) |
United States (USA) |
| Colloca, Stefano (Nouscom 201806 CTO) |
Chief Technology/Technical Officer (CTO) |
Nouscom (Group) |
Switzerland |
| Colpan, Metin (Qiagen CEO + co-founder) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
Germany |
| Colsman, Wolfgang (Zontal 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
| Comb, Michael J. (Cell Signaling Technology 200907 CEO + Founder) |
Chief Executive Officer (CEO) |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
| Combal, Jean-Philippe (Vivet Therapeutics 201705 CEO + Co-Founder before Gensight Biologics + Sanofi) |
Chief Executive Officer (CEO) |
Vívet Therapeutics (Group) |
France |
| Combé, Nicolas (Formycon CFO before Nanohale 201102 CFO) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Germany |
| Compton, Carolyn (Arizon State Univ + Mayo Clinic 201502 Professor + former Director of NCI OBBR) |
Professor |
Arizona State University (ASU) |
United States (USA) |
| Conca, James (RJ Lee Group 201306 Director Analytical Services) |
President/Director/Head Business Group/Unit/Division |
RJ Lee Group Inc. |
United States (USA) |
| Condie, Jamie (BD Diagnostics 200807 VP + General Manger) |
n. a. |
Becton, Dickinson (Group) |
United States (USA) |
| Condon, Liam (Bayer 201212– CEO of Bayer CropScience before Managing Director Bayer Vital before Schering) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Connelly, Robert T. (Elicio Therapeutics 201903– CEO before Pronutria + Pulmatrix + Diversys/Domantis + IGEN Intl) |
Chief Executive Officer (CEO) |
|
|
| Conni, Mario (Eurofins 201410– Managing Director of Eurofins Genomics Srl) |
Managing Director |
Eurofins (Group) |
Italy |
| Connor, Ed (Peak Scientific 201302– GC/MS Product Specialist before ETHZ + Univ Zürich) |
Support Manager / Service Manager |
Peak Scientific (Group) |
United Kingdom (GB) |
| Conquet, Francois (Prexton Therapeutics 201207– CEO + founder) |
Chief Executive Officer (CEO) |
Lundbeck (Group) |
Switzerland |
| Conradt, Monika (Evotec 201606– Global Head Human Resources before Boehringer HR Manager Europe) |
Human Resources Manager |
Evotec (Group) |
Germany |
| Constant, Samuel (Epithelix 201207 COO + Co-founder) |
Chief Operating Officer (COO) |
Epithelix Sàrl |
Switzerland |
| Conterno, Enrique (Eli Lilly 199201– President Lilly USA) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Conway, Christopher (ABCell-Bio SAS 201508 CEO) |
Chief Executive Officer (CEO) |
ABCell-Bio SAS |
France |
| Conway, Martin (Randox 202404 Sales Manager) |
Sales Manager / Marketing Manager |
Randox (Group) |
United Kingdom (GB) |
| Cook, Kathryn (NuCicer 202211 CEO + Co-Founder) |
n. a. |
|
|
| Cook, Mondana (PBD Biotech 202207– COO before Kinomica + Qiagen) |
Chief Operating Officer (COO) |
PBD Biotech (Group) |
United Kingdom (GB) |
| Cooley, Margaret M. (Photonis 201512 International Marketing Manager at Photonis USA) |
Sales Manager / Marketing Manager |
Photonis (Group) |
United States (USA) |
| Coon, Joshua (Univ Wisconsin 201506 Professor) |
Professor |
University of Wisconsin System |
United States (USA) |
| Cooper, Ashley (Reinnervate 200709– CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United Kingdom (GB) |
| Coorey, David (Agena Bioscience 201607– VP + Managing Director EMEA before BD + Affymetrix + Gambro + Fresenius Kabi) |
Regional manager |
Agena Bioscience Inc. |
United States (USA) |
| Coppard, Nicholas (Santhera 201502– appointed SVP Head Development) |
Research & Development Manager |
Santhera (Group) |
Switzerland |
| Coquoz, Didier (Oncalis 200810 CEO) |
Chief Executive Officer (CEO) |
Oncalis AG |
Switzerland |
| Corazza, Sabrina (Axxam 201603 Director Business Development) |
Business Development Manager / Strategy Manager |
Axxam S.p.A. |
Italy |
| Corbett, Jim (Emulate 202003– CEO before PerkinElmer + ViaCell CADx Systems + Abbott) |
President/Director/Head Business Group/Unit/Division |
Emulate Inc. |
United States (USA) |
| Cordes, Ralf (Ascienion 200902 Technology Manager) |
IP Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Cordes, Ulrik (Biocartis 201309– CCO before Thermo Fisher + Dako A/S + Pharmacia Biotech A/S) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Switzerland |
| Cornaglia, Matteo (Nagi Bioscience 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nagi Bioscience S.A. |
Switzerland |
| Cornall, Jim (Inova Software 202205– Editor-in-Chief at Labiotech.eu formerly Editor at DairyReporter) |
Editor / Publisher |
Inpart (Group) |
Germany |
| Cornett, Shannon (Bruker 201305 Applications Developm Manager) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
| Corr, David (EKF Diagnostics 201307– CTO before Head of RnD) |
Chief Technology/Technical Officer (CTO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Corr, Peter B. (Celtic Therapeutics 2007 Managing General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
| Corriveau, Jacques (AstraZeneca 201711– General Manager North America at Definiens) |
General Manager (management) |
AstraZeneca (Group) |
United States (USA) |
| Corsico, Christopher (Boehringer 201708 CMO) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 13 14 15 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
